Articles From: Vascular Solutions Receives 510(k) Clearance for Turnpike(TM) Catheters to Vecima Announces Voting Results for Annual and Special Meeting


Unique over-the-wire catheters with a proprietary braid and dual-layer coil shaft to provide superior flexibility and torque response Soft Tip version designed to navigate tight curves in tortuous vessels Hard Tip version designed for use in traversing difficult lesions MINNEAPOLIS, Dec.
Sign-up for Vascular Solutions Receives 510(k) Clearance for Turnpike(TM) Catheters investment picks
- Record quarterly revenues increase 14% to $31.9 million, exceeding the top end of guidance - GAAP EPS of $0.15, including the impact of a non-cash deferred tax asset adjustment that reduced earnings by $0.05 - Raising 2014 revenue guidance to a range of $125 million to $126 million, representing growth of 14% at new midpoint - Revising 2014 GAAP EPS guidance to a range of $0.65-$0.67, reflecting the Q3 non-cash tax adjustment and elevated legal expenses MINNEAPOLIS, Oct.
Sign-up for Vascular Solutions Reports Third Quarter Results investment picks
After nearly three years on the market, reprocessing service for popular vein ablation catheter continues to gain customers and demonstrate reliable outcomes Excellent safety record established, with no serious adverse patient events reported since reprocessing began in January of 2012 Reprocessing results in significant cost savings and reduced medical waste for U.S. vein clinics MINNEAPOLIS, Jan.
Sign-up for Vascular Solutions Surpasses 75,000 Successfully Reprocessed ClosureFAST(R) Catheters investment picks
MINNEAPOLIS, Nov.
Sign-up for Vascular Solutions to Distribute PolarCath(TM) Peripheral Dilatation System investment picks
MINNEAPOLIS, Nov.
Sign-up for Vascular Solutions to Present at the 2014 Stifel Nicolaus Healthcare Conference investment picks
MINNEAPOLIS, Jan.
Sign-up for Vascular Solutions, Inc. to Webcast Fourth Quarter Conference Call investment picks
CAMBRIDGE, Mass., Nov.
Sign-up for VBI Reports Third Quarter 2014 Financial Results and Provides Update on CMV Vaccine Development investment picks
Los Angeles, CA, Dec.
Sign-up for VBI to Present at the Equities.com Small-Cap Stars Conference investment picks
2014/11/24
Jeff Baxter, VBI's President and CEO, has been invited to speak at the LD Micro Conference in Los Angeles, CA on December 3 rd , 2014.
Sign-up for VBI to Present at the LD Micro Conference investment picks
CAMBRIDGE, Mass., Jan.
Sign-up for VBI Vaccines Partners with Le Classique to Raise CMV Awareness in Canada investment picks
CAMBRIDGE, Mass., Jan.
Sign-up for VBI Vaccines to Present at the Noble Financial Capital Markets Equity Conference investment picks
TEL AVIV, Israel, Oct.
Sign-up for VBL Therapeutics Announces Closing of Initial Public Offering investment picks
TEL AVIV, Israel, Dec.
Sign-up for VBL Therapeutics Announces Positive Phase 2a Data for VB-111 in Recurrent Thyroid Cancer investment picks
TEL AVIV, Israel, Jan.
Sign-up for VBL Therapeutics Announces Ron Cohen and Philip Serlin Nominated to Board of Directors investment picks
TEL AVIV, Israel, Nov.
Sign-up for VBL Therapeutics Announces Third Quarter 2014 Financial Results investment picks
TEL AVIV, Israel, Nov.
Sign-up for VBL Therapeutics to Present Company Overview at Upcoming Conferences investment picks
-- Interim Data Suggest Improved Overall Survival in Patients Treated With VB-111 in Combination With Bevacizumab (Avastin®) --
Sign-up for VBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO) investment picks
TEL AVIV, Israel, Nov.
Sign-up for VBL Therapeutics to Report Third Quarter 2014 Financial Results on November 13, 2014 investment picks
VCA Inc. (NASDAQ: WOOF) , a leading animal healthcare company in the United States and Canada, today reported financial results for the third quarter ended September 30, 2014, as follows: revenue increased 7.7% to a third quarter record of $499.6 million; gross profit increased 11.8% to $123.8 million; operating income of $53.5 million; net income of $27.5 million and diluted earnings per common share of $0.31. Non-GAAP earnings per diluted common share excluding acquisition-related amortization, a non-cash impairment charge and debt retirement costs ("Adjusted EPS Excluding Amortization") increased 19.1% to $0.56. Our results for the quarter included a non-cash impairment charge of $27.0 million, $17.0 million net of tax, or $0.20 per common share, related to the write-down of goodwill and other long-lived assets in our Vetstreet business.
Sign-up for VCA Inc. Reports Third Quarter 2014 Results investment picks
VCA Inc. (NASDAQ: WOOF), a leading animal healthcare company in the United States, will present at the 26th Annual Piper Jaffray Healthcare Conference on Tuesday, December 2, 2014, in New York at The New York Palace Hotel.
Sign-up for VCA Inc. to Present at 26th Annual Piper Jaffray Healthcare Conference investment picks
VCA Inc. (NASDAQ: WOOF), a leading animal healthcare company in the United States, will present at Stephens Fall Investment Conference on Tuesday, November 11, 2014, in New York at The New York Palace Hotel.
Sign-up for VCA Inc. to Present at Stephens Fall Investment Conference investment picks
VCA Inc. (NASDAQ: WOOF) , a leading animal healthcare company in the United States, will present at Stifel Healthcare Conference on Tuesday, November 18, 2014, in New York at The New York Palace Hotel.
Sign-up for VCA Inc. to Present at Stifel Healthcare Conference investment picks
2014/12/15
VCA has partnered with award winning country music recording artist Miranda Lambert’s MuttNation’s Redemption Ranch, a private, no-kill shelter/sanctuary in Tishomingo, Oklahoma that celebrated its grand re-opening last weekend.
Sign-up for VCA Partners with Miranda Lambert’s MuttNation Redemption Ranch with Complimentary Healthy Start Certificates for Adopting Families investment picks
2015/1/9
VCA has teamed up with the Los Angeles Kings in an ongoing partnership that includes fundraisers and volunteer events and activities for the benefit of animals in need.
Sign-up for VCA Teams Up with the Los Angeles Kings to Support Animal Welfare investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978999001&sourceType=1 http://www.ccnmatthews.com/logos/20070809-vcm.gif VICTORIA, BRITISH COLUMBIA --
Sign-up for Vecima Announces Voting Results for Annual and Special Meeting investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Vascular Solutions Receives 510(k) Clearance for Turnpike(TM) Catheters to Vecima Announces Voting Results for Annual and Special Meeting
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent